Global Covid-19 Serology Testing Market Overview And Scope:
Global Covid-19 Serology Testing Market Size was estimated at USD xx million in 2022 and is projected to reach USD xx million by 2028, exhibiting a CAGR of xx% during the forecast period.
The Global Covid-19 Serology Testing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Covid-19 Serology Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, Cellex, Innovita Biological Technology, Zhejiang Orient Gene Biotech, Ortho Clinical Diagnostics, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), Chembio Diagnostics, Safecare Bio-Tech
Global Covid-19 Serology Testing Market Segmentation
By Type, Covid-19 Serology Testing market has been segmented into:
Rapid Diagnostic Test (RDT)
Chemiluminescent Immunoassay
Other
By Application, Covid-19 Serology Testing market has been segmented into:
Hospitals
Third-party laboratory
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Covid-19 Serology Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Covid-19 Serology Testing market.
Top Key Players Covered in Covid-19 Serology Testing market are:
Abbott
Guangzhou Wondfo Biotech
BioMedomics
Kantaro
Roche
Cellex
Innovita Biological Technology
Zhejiang Orient Gene Biotech
Ortho Clinical Diagnostics
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
Chembio Diagnostics
Safecare Bio-Tech
Objective to buy this Report:
1. Covid-19 Serology Testing analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Covid-19 Serology Testing market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Covid-19 Serology Testing Market by Type
5.1 Covid-19 Serology Testing Market Overview Snapshot and Growth Engine
5.2 Covid-19 Serology Testing Market Overview
5.3 Rapid Diagnostic Test (RDT)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Rapid Diagnostic Test (RDT): Geographic Segmentation
5.4 Chemiluminescent Immunoassay
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Chemiluminescent Immunoassay: Geographic Segmentation
5.5 Other
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Other: Geographic Segmentation
Chapter 6: Covid-19 Serology Testing Market by Application
6.1 Covid-19 Serology Testing Market Overview Snapshot and Growth Engine
6.2 Covid-19 Serology Testing Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Third-party laboratory
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Third-party laboratory: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Covid-19 Serology Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Covid-19 Serology Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Covid-19 Serology Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 GUANGZHOU WONDFO BIOTECH
7.4 BIOMEDOMICS
7.5 KANTARO
7.6 ROCHE
7.7 CELLEX
7.8 INNOVITA BIOLOGICAL TECHNOLOGY
7.9 ZHEJIANG ORIENT GENE BIOTECH
7.10 ORTHO CLINICAL DIAGNOSTICS
7.11 GUANGDONG HECIN-SCIENTIFIC
7.12 DYNAMIKER BIOTECHNOLOGY (TIANJIN)
7.13 CHEMBIO DIAGNOSTICS
7.14 SAFECARE BIO-TECH
Chapter 8: Global Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Rapid Diagnostic Test (RDT)
8.2.2 Chemiluminescent Immunoassay
8.2.3 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Third-party laboratory
Chapter 9: North America Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Rapid Diagnostic Test (RDT)
9.4.2 Chemiluminescent Immunoassay
9.4.3 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Third-party laboratory
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Rapid Diagnostic Test (RDT)
10.4.2 Chemiluminescent Immunoassay
10.4.3 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Third-party laboratory
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Rapid Diagnostic Test (RDT)
11.4.2 Chemiluminescent Immunoassay
11.4.3 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Third-party laboratory
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Rapid Diagnostic Test (RDT)
12.4.2 Chemiluminescent Immunoassay
12.4.3 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Third-party laboratory
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Rapid Diagnostic Test (RDT)
13.4.2 Chemiluminescent Immunoassay
13.4.3 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Third-party laboratory
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Covid-19 Serology Testing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Rapid Diagnostic Test (RDT)
14.4.2 Chemiluminescent Immunoassay
14.4.3 Other
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Third-party laboratory
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Covid-19 Serology Testing Scope:
|
Report Data
|
Covid-19 Serology Testing Market
|
|
Covid-19 Serology Testing Market Size in 2025
|
USD XX million
|
|
Covid-19 Serology Testing CAGR 2025 - 2032
|
XX%
|
|
Covid-19 Serology Testing Base Year
|
2024
|
|
Covid-19 Serology Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, Cellex, Innovita Biological Technology, Zhejiang Orient Gene Biotech, Ortho Clinical Diagnostics, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), Chembio Diagnostics, Safecare Bio-Tech.
|
|
Key Segments
|
By Type
Rapid Diagnostic Test (RDT)
Chemiluminescent Immunoassay
Other
By Applications
Hospitals
Third-party laboratory
|
